483
Barbara E. Rizzardi, MDFDA 483 - Barbara E. Rizzardi, MD - December 02, 2022
Record Details
An FDA inspection of Barbara E. Rizzardi, MD, a Principal Investigator in West Jordan, UT, revealed a significant failure to conduct an investigation in accordance with the signed statement of investigator. Specifically, a subject was improperly enrolled in a clinical trial despite having positive serology tests that violated exclusion criteria. This indicates a serious lapse in adherence to study protocols and investigator responsibilities.
- Office
- Denver District Office
- Person
Open in Dashboard
ID · 6f4908c4-8e87-4e32-bcf9-4c4962d6a093